In fact, an increase in the levels of activated effector memory T cells and central memory T cell subsets of CD4+ and CD8+ T cells, and activated Th1 plus T-helper follicular 1 cells was observed in melanoma patients treated with anti-PD-1 antibodies [53]. Here, CD8A is linked to melanoma.